Ernexa Therapeutics Inc. (ERNAW) Warrants

✓ ConfirmedNASDAQCompany warrantstrike $17.001/25 share per warrantexpires 2031-02-10updated 2026-11-20

Each ERNAW warrant gives the holder the right to buy 1/25 share of Ernexa Therapeutics Inc. at $17.00 per share, until February 10, 2031. The stock last closed at $1.63, below the strike, so the warrant is out of the money. Ernexa Therapeutics Inc. has a market value of about $2.76M. There are 856.30K listed warrants; exercising all of them would add 2.0% to the 1.69M shares outstanding.

Ernexa Therapeutics Inc. reports its business to the SEC as “Pharmaceutical Preparations”, with its head office in Cambridge, MA; it is incorporated in Delaware. Its latest SEC filing was on November 19, 2026: current report (directors or officers changed), form 8-K. The warrant closed at $0.0326 on November 19, 2026, down 67% from $0.1000 on February 6, 2026. ERNA trades at 9.6% of the strike; it would have to rise about 10-fold to reach it.

Thinly traded: ERNAW traded about $99 a day over the last 30 days, and on only 15 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.

Warrant price
$0.0326
last close
ERNA share price
$1.63
10% of strike
Market cap
$2.76M
1.69M shares
Time left
1,543 days
expires 2031-02-10
Dilution if exercised
2.0%
856.30K warrants

Key terms

Strike per share
$17.00
Shares per warrant
1/25
Cash to exercise one warrant
$0.6800
Expiry
2031-02-10
Redemption trigger
none stated
Cashless exercise
no
Break-even stock price
$17.82

From the issuer's S-1/A (2026-02-05).

Exercise calculator

Each warrant buys 1/25 share at $17.00. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.

Company and stock

Company
Ernexa Therapeutics Inc.
Underlying stock
ERNA
Share price
$1.63
Market cap
$2.76M
Shares outstanding
1.69M
12-month range
$1.62 – $37.00
12-month change
-96%
Value of all listed warrants
$27.92K (1.0% of market cap)
Industry
Pharmaceutical Preparations
Head office
Cambridge, MA
Incorporated in
Delaware

Market cap is the last share price times shares outstanding (as of 2026-11-06). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.

Model value Pro · free for now

$0.0109per warrant, our estimate · low confidence

The stock is at 10% of the strike; this far from it the answer is mostly a guess about volatility.

Last price
$0.0326
Low and high estimate
$0.0011 – $0.0211
Stock volatility, measured
147%
Volatility we use
50% · 80% · 100%
Volatility the price implies
122%
Effect of dilution
−0.4%
Method
exact Black-Scholes formula

The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.

Dilution

Shares outstanding
1.69M
Listed warrants
856.30K
Dilution if all exercised
2.0%

Warrant count from the data the company files with the SEC.

Filings

The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.

Events

Questions about ERNAW

When does the ERNAW warrant expire?

ERNAW expires on February 10, 2031.

What is the strike price of ERNAW?

$17.00 per share; each warrant converts into 1/25 share, so exercising one warrant costs $0.6800.

Can Ernexa Therapeutics Inc. redeem the ERNAW warrants early?

The source filing we read lists no stock-price redemption trigger.

How many ERNAW warrants are outstanding?

856.30K listed warrants, equal to 2.0% dilution if all are exercised.

Related warrants

Get an email when alerts open

Follow ERNAW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.